NAFDAC discloses why COVID-19 vaccine will be administered without clinical trial
The planned roll-out of coronavirus vaccines in Nigeria, which is expected to begin in this January will not be subjected to fresh clinical trials before they are administered to citizens, this is according to the National Agency for food and drug administration, NAFDAC.
Sayo Akintola, the spokesman of the agency made this known during an interview with newsmen said local trials for the vaccine were unnecessary since the vaccine was already certified by the World Health Organisation.
“The truth is that once a vaccine is approved by the WHO, it is assumed that it has passed through some preliminary stages of the trial.
“It is a known fact that for the WHO to sanction a vaccine, it must have gone through a series of trials here and there,” he said.
He, however, explained that a sample of the vaccine will be taken to the lab for its “safety and efficacy” to be ascertained before inoculation.
Recall that the Nigeria Medical Association had asked the federal government to do its evaluation of the coronavirus vaccine before administering it on Nigerians.
But with NAFDAC’s position, Nigeria’s health authorities may very well proceed with vaccinations, trusting WHO’s expertise.